Kyverna Therapeutics (KYTX) announced the appointment of Mayo Pujols as its Chief Technology Officer, CTO, effective February 9, 2026. Most recently, Pujols served as Chief Operating Officer of Castle Creek Biosciences
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KYTX:
- Kyverna Therapeutics: Strong Early Autoimmune CAR-T Data, Accelerated SPS Timeline, and Solid Cash Runway Support Buy Rating
- Kyverna Therapeutics Names Christi Shaw Executive Board Chair
- Kyverna Therapeutics provides corporate update, priorities for 2026
- Kyverna Therapeutics Announces $100 Million Public Offering
- Midday Fly By: Warner Bros. urges investors to reject Paramount bid